These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 6883318

  • 1. Effects of biologically active metabolites of tamoxifen on the proliferation kinetics of MCF-7 human breast cancer cells in vitro.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1983 Oct; 43(10):4618-24. PubMed ID: 6883318
    [Abstract] [Full Text] [Related]

  • 2. Effects of pharmacological concentrations of estrogens on proliferation and cell cycle kinetics of human breast cancer cell lines in vitro.
    Reddel RR, Sutherland RL.
    Cancer Res; 1987 Oct 15; 47(20):5323-9. PubMed ID: 3652038
    [Abstract] [Full Text] [Related]

  • 3. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen.
    Reddel RR, Murphy LC, Hall RE, Sutherland RL.
    Cancer Res; 1985 Apr 15; 45(4):1525-31. PubMed ID: 3978620
    [Abstract] [Full Text] [Related]

  • 4. Antiestrogen binding in antiestrogen growth-resistant estrogen-responsive clonal variants of MCF-7 human breast cancer cells.
    Miller MA, Lippman ME, Katzenellenbogen BS.
    Cancer Res; 1984 Nov 15; 44(11):5038-45. PubMed ID: 6488162
    [Abstract] [Full Text] [Related]

  • 5. Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture.
    Osborne CK, Boldt DH, Estrada P.
    Cancer Res; 1984 Apr 15; 44(4):1433-9. PubMed ID: 6704960
    [Abstract] [Full Text] [Related]

  • 6. Interactions of antiestrogens with human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Treat Rep; 1976 Oct 15; 60(10):1421-9. PubMed ID: 1035504
    [Abstract] [Full Text] [Related]

  • 7. Antiestrogenic potency and binding characteristics of the triphenylethylene H1285 in MCF-7 human breast cancer cells.
    Sheen YY, Ruh TS, Mangel WF, Katzenellenbogen BS.
    Cancer Res; 1985 Sep 15; 45(9):4192-9. PubMed ID: 4040807
    [Abstract] [Full Text] [Related]

  • 8. Structure-activity relationships of nonisomerizable derivatives of tamoxifen: importance of hydroxyl group and side chain positioning for biological activity.
    Murphy CS, Parker CJ, McCague R, Jordan VC.
    Mol Pharmacol; 1991 Mar 15; 39(3):421-8. PubMed ID: 2005879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.
    Coezy E, Borgna JL, Rochefort H.
    Cancer Res; 1982 Jan 15; 42(1):317-23. PubMed ID: 7053859
    [Abstract] [Full Text] [Related]

  • 11. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X, Pisha E, Tonetti DA, Yao D, Li Y, Yao J, Burdette JE, Bolton JL.
    Chem Res Toxicol; 2003 Jul 15; 16(7):832-7. PubMed ID: 12870885
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Differential effects of tamoxifen and analogs with nonbasic side chains on cell proliferation in vitro.
    Murphy LC, Sutherland RL.
    Endocrinology; 1985 Mar 15; 116(3):1071-8. PubMed ID: 3971898
    [Abstract] [Full Text] [Related]

  • 15. Cell cycle analysis of estrogen stimulation and antiestrogen inhibition of growth of the human breast cancer cell line MCF-7.
    Lykkesfeldt AE, Larsen JK, Christensen IJ.
    Breast Cancer Res Treat; 1986 Mar 15; 7 Suppl():S83-90. PubMed ID: 3742066
    [Abstract] [Full Text] [Related]

  • 16. Drug and hormone sensitivity of estrogen receptor-positive and -negative human breast cancer cells in vitro.
    Goldenberg GJ, Froese EK.
    Cancer Res; 1982 Dec 15; 42(12):5147-51. PubMed ID: 7139616
    [Abstract] [Full Text] [Related]

  • 17. Guide-lines in the design of new antiestrogens and cytotoxic-linked estrogens for the treatment of breast cancer.
    Leclercq G, Devleeschouwer N, Heuson JC.
    J Steroid Biochem; 1983 Jul 15; 19(1A):75-85. PubMed ID: 6887875
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting the sensitivity of T-47D human breast cancer cells to tamoxifen.
    Reddel RR, Murphy LC, Sutherland RL.
    Cancer Res; 1984 Jun 15; 44(6):2398-405. PubMed ID: 6722780
    [Abstract] [Full Text] [Related]

  • 19. The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture.
    Lippman M, Bolan G, Huff K.
    Cancer Res; 1976 Dec 15; 36(12):4595-601. PubMed ID: 1000504
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.